Hawaii Biotech, Inc.
Records under this name other than the patents Hawaii Biotech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,198,079 | Synthetic Expression Vectors for Insect Cells Formerly held In force · High confidence | In force | High confidence | |
| US 11,434,261 | Optimized Zika Virus Envelope Gene and Expression Thereof Lapsed on the fee record Ended Sep 6, 2026 · High confidence | Lapsed on the fee record | Ended Sep 6, 2026 | High confidence |
| US 10,039,820 | West Nile Virus Vaccine Comprising WN-80E Recombinant Subunit Protein Lapsed on the fee record Ended Aug 7, 2026 · High confidence | Lapsed on the fee record | Ended Aug 7, 2026 | High confidence |
| US 11,299,461 | Pyridin-2-yl alkylamino substituted hydroxamic acid and uses thereof Lapsed on the fee record Ended Apr 12, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 12, 2026 | USPTO record |
| US 7,247,752 | Methods for the synthesis of astaxanthin Formerly held Term ended Term ended Oct 3, 2025 · USPTO record | Term ended | Term ended Oct 3, 2025 | USPTO record |
| US 7,521,584 | Carotenoid analogs or derivatives for the inhibition and amelioration of disease Formerly held Term ended Term ended May 27, 2024 · USPTO record | Term ended | Term ended May 27, 2024 | USPTO record |
| US 7,320,997 | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease Formerly held Term ended Term ended Jan 4, 2024 · USPTO record | Term ended | Term ended Jan 4, 2024 | USPTO record |
| US 7,145,025 | Structural carotenoid analogs for the inhibition and amelioration of disease Formerly held Term ended Term ended Oct 9, 2023 · USPTO record | Term ended | Term ended Oct 9, 2023 | USPTO record |
| US 7,317,008 | Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury Formerly held Term ended Term ended Sep 23, 2023 · USPTO record | Term ended | Term ended Sep 23, 2023 | USPTO record |
| US 7,345,091 | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease Formerly held Term ended Term ended Jul 29, 2023 · USPTO record | Term ended | Term ended Jul 29, 2023 | USPTO record |